Median age (range) y.o. | 35 (1–75) |
---|---|
Male: female | 69: 34 |
Distribution of cases in age groupa, N(%) | |
 1 - ≤5 years | 2/153 (1.3%) |
 6 - ≤18 years | 19/190 (10%) |
 19 - ≤45 years | 53/378 (14%) |
 > 45 years | 29/254 (11.4%) |
Day of onset (median, range), days | 5 (1–12) |
Length of stay (median, range), days | 6 (1–36) |
Antibiotics use from 90 subjects with documented history, N (%) | 76 (84%) |
 Ceftriaxone | 17 (22.4%) |
 Ciprofloxacin | 9 (11.8%) |
 Levofloxacin | 9 (11.8%) |
 Cefixime | 2 (2.6%) |
 Cefotaxime, Amoxicillin, Ampicillin, Cefadroxil, Meropenem, Chloramphenicol, Cefoperazone, Sulbactam, Cotrimoxazole | 1 (1.3%), each |
 Combination 2–3 antibiotics | 30 (39.5%) |
Outcomes, N (%) | |
 Recovered | 72 (69.9%) |
 Recovered with sequelaeb | 24 (23.3%) |
 Died | 7 (6.8%) |
By sitesa, N (%) | |
 Bandung | 22/189 (11.6%) |
 Denpasar | 16/101 (15.8%) |
 Jakarta | 7/87 (8%) |
 Makassar | 5/131 (3.8%) |
 Semarang | 21/191 (10.9%) |
 Surabaya | 26/156 (16.7%) |
 Yogyakarta | 6/120 (5%) |